凱旺科技(301182.SZ):擬使用不超0.5億元自有資金、5億元閒置募集資金進行現金管理
格隆匯12月29日丨凱旺科技(301182.SZ)公佈,公司於2021年12月28日召開了第二屆董事會第十二次會議和第二屆監事會第八次會議,審議通過了《關於使用自有資金進行現金管理的議案》、《關於使用閒置募集資金進行現金管理的議案》,在確保不影響募集資金投資計劃正常進行和募集資金安全的情況下,同意公司使用不超過人民幣5000萬元(含本數)自有資金和5億元(含本數)閒置募集資金進行現金管理,用於投資安全性高、流動性好的金融機構的現金管理類產品,有效期自公司股東大會審議通過之日起12個月內。在上述使用期限及額度範圍內,資金可以循環滾動使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.